Pulmonx Corp (LUNG): Shareholders' Equity

Annual figures by period end, from SEC filings.

$54.12M
As of 2025-12-31
$39.20M
As of 2026-06-30
-29.4%
3-year compound annual growth
-24.9%
5-year compound annual growth
$226.13M2018-12-31: -$167.33M2019-12-31: -$187.38M2020-12-31: $226.13M2021-12-31: $193.24M2022-12-31: $154.01M2023-12-31: $118.31M2024-12-31: $85.81M2025-12-31: $54.12M$54.12M
2018-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$54.12M-36.9%2026-03-10, Balance as of period end
2024-12-31$85.81M-27.5%2026-03-10, Balance as of period end
2023-12-31$118.31M-23.2%2025-02-25, Balance as of period end
2022-12-31$154.01M-20.3%2024-02-27, Balance as of period end
2021-12-31$193.24M-14.5%2023-03-01, Balance as of period end
2020-12-31$226.13Mn/m2022-03-01, Balance as of period end
2019-12-31-$187.38Mn/m2021-03-15, Balance as of period end
2018-12-31-$167.33Mn/a2021-03-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Pulmonx Corp (LUNG)2025-12-31$54.12M-36.9%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$259.66M+26.4%
Delcath Systems, Inc. (DCTH)2025-12-31$111.22M+61.8%
Iradimed Corp (IRMD)2025-12-31$94.62M+9.0%
NeuroPace Inc (NPCE)2025-12-31$19.03M+137.5%
Beta Bionics, Inc. (BBNX)2025-12-31$287.61Mn/m
TELA Bio, Inc. (TELA)2025-12-31$6.31M-77.8%
PRO DEX Inc (PDEX)2026-06-30$47.63M+30.0%
Sight Sciences, Inc. (SGHT)2025-12-31$63.94M-26.9%

Compare LUNG, KMTS, DCTH, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗